StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
LIVN

LivaNova PLC

LIVN Nasdaq Electromedical & Electrotherapeutic Apparatus EDGAR ↗
$85.33
+2.87 +3.47%

Key statistics

from XBRL data in SEC filings
Market cap
$4.69B
Revenue (TTM)
$1.43B
Net income (TTM)
$107M
EPS (TTM)
$1.96
P/E ratio
43.5
Dividend yield
Free cash flow
$173M
Cash
$540M
Total assets
$2.52B
Gross margin
67.5%
52-week range
$41.87 – $85.76

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Results of operations (earnings release) Aug 5, 2026 8-K Shareholder vote results Jun 11, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Results of operations (earnings release) May 6, 2026 10-K Fiscal year ended 2025-12-31 Feb 25, 2026 8-K Results of operations (earnings release) Feb 25, 2026 8-K Director or officer change Jan 14, 2026 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 8-K Director or officer change Sep 4, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Director or officer change; Shareholder vote results Jun 11, 2025 8-K Regulation FD disclosure May 21, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Results of operations (earnings release) May 7, 2025 8-K Regulation FD disclosure Mar 17, 2025 10-K Fiscal year ended 2024-12-31 Feb 25, 2025 8-K Results of operations (earnings release) Feb 25, 2025 8-K Regulation FD disclosure Nov 1, 2024 10-Q Quarter ended 2024-09-30 Oct 31, 2024 8-K Results of operations (earnings release) Oct 30, 2024 8-K Director or officer change Oct 8, 2024 8-K Director or officer change Sep 10, 2024 10-Q Quarter ended 2024-06-30 Aug 1, 2024 8-K Results of operations (earnings release) Jul 31, 2024 8-K Director or officer change; Shareholder vote results Jun 12, 2024 10-Q Quarter ended 2024-03-31 May 3, 2024 8-K Results of operations (earnings release); Regulation FD disclosure May 1, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Mar 8, 2024 8-K Regulation FD disclosure Mar 6, 2024 8-K Regulation FD disclosure Mar 4, 2024 10-K Fiscal year ended 2023-12-31 Feb 29, 2024 8-K Results of operations (earnings release) Feb 21, 2024 8-K Director or officer change; Other events Feb 5, 2024 8-K Exit or disposal costs; Material impairment Jan 8, 2024 8-K Other events Dec 13, 2023 8-K Other events Dec 6, 2023 8-K Other events Nov 20, 2023 10-Q Quarter ended 2023-09-30 Nov 1, 2023